Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
71,197
Sort by:
Dental Pain R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF DENTAL PAIN PIPELINE REPORT INCLUDES Panorama of Dental Pain pipeline markets including statistics on therapeutic drugs and companies involved Dental Pain Pipeline candidates across various development ...
August 2018
30 pages
Dermatomycoses R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF DERMATOMYCOSES PIPELINE REPORT INCLUDES Panorama of Dermatomycoses pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Dermatomyositis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF DERMATOMYOSITIS PIPELINE REPORT INCLUDES Panorama of Dermatomyositis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
160 pages
Diabetic Foot Ulcers R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF DIABETIC FOOT ULCERS PIPELINE REPORT INCLUDES Panorama of Diabetic Foot Ulcers pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Foot Ulcers Pipeline candidates across various development ...
August 2018
110 pages
Diabetic Gastroparesis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF DIABETIC GASTROPARESIS PIPELINE REPORT INCLUDES Panorama of Diabetic Gastroparesis pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Gastroparesis Pipeline candidates across various development ...
August 2018
50 pages
Diabetic Neuropathic Pain R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF DIABETIC NEUROPATHIC PAIN PIPELINE REPORT INCLUDES Panorama of Diabetic Neuropathic Pain pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Neuropathic Pain Pipeline candidates across various development ...
August 2018
80 pages
Diabetic Neuropathy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF DIABETIC NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Diabetic Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Neuropathy Pipeline candidates across various development ...
August 2018
80 pages
Diabetic Peripheral Neuropathy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF DIABETIC PERIPHERAL NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Diabetic Peripheral Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Diabetic Peripheral Neuropathy Pipeline candidates across various development ...
August 2018
60 pages
Diarrhea R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF DIARRHEA PIPELINE REPORT INCLUDES Panorama of Diarrhea pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
120 pages
Dilated Cardiomyopathy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF DILATED CARDIOMYOPATHY PIPELINE REPORT INCLUDES Panorama of Dilated Cardiomyopathy pipeline markets including statistics on therapeutic drugs and companies involved Dilated Cardiomyopathy Pipeline candidates across various development ...
August 2018
50 pages
Diphtheria R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF DIPHTHERIA PIPELINE REPORT INCLUDES Panorama of Diphtheria pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Down Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF DOWN SYNDROME PIPELINE REPORT INCLUDES Panorama of Down Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Down Syndrome Pipeline candidates across various development ...
August 2018
50 pages
Dravet Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF DRAVET SYNDROME PIPELINE REPORT INCLUDES Panorama of Dravet Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Dravet Syndrome Pipeline candidates across various development ...
August 2018
60 pages
Drug Addiction R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... ready to use format. SCOPE OF DRUG ADDICTION PIPELINE REPORT INCLUDES Panorama of Drug Addiction pipeline markets including statistics on therapeutic drugs and companies involved Drug Addiction Pipeline candidates across various development ...
August 2018
130 pages
Dupuytren Contracture R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF DUPUYTREN CONTRACTURE PIPELINE REPORT INCLUDES Panorama of Dupuytren Contracture pipeline markets including statistics on therapeutic drugs and companies involved Dupuytren Contracture Pipeline candidates across various development ...
August 2018
20 pages
Dyskinesia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF DYSKINESIA PIPELINE REPORT INCLUDES Panorama of Dyskinesia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
130 pages
Dystonia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF DYSTONIA PIPELINE REPORT INCLUDES Panorama of Dystonia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Eastern Equine Encephalitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF EASTERN EQUINE ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Eastern Equine Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved Eastern Equine Encephalitis Pipeline candidates across various development ...
August 2018
30 pages
Emphysema R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF EMPHYSEMA PIPELINE REPORT INCLUDES Panorama of Emphysema pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Encephalitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Encephalomyelitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF ENCEPHALOMYELITIS PIPELINE REPORT INCLUDES Panorama of Encephalomyelitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Encephalopathy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF ENCEPHALOPATHY PIPELINE REPORT INCLUDES Panorama of Encephalopathy pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
End Stage Renal Disease (ESRD) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF END STAGE RENAL DISEASE (ESRD) PIPELINE REPORT INCLUDES Panorama of End Stage Renal Disease (ESRD) pipeline markets including statistics on therapeutic drugs and companies involved End Stage Renal Disease (ESRD) Pipeline candidates across ...
August 2018
40 pages
Endometriosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF ENDOMETRIOSIS PIPELINE REPORT INCLUDES Panorama of Endometriosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
110 pages
Enterocolitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF ENTEROCOLITIS PIPELINE REPORT INCLUDES Panorama of Enterocolitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Eosinophilic Esophagitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF EOSINOPHILIC ESOPHAGITIS PIPELINE REPORT INCLUDES Panorama of Eosinophilic Esophagitis pipeline markets including statistics on therapeutic drugs and companies involved Eosinophilic Esophagitis Pipeline candidates across various development ...
August 2018
50 pages
Ependymoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF EPENDYMOMA PIPELINE REPORT INCLUDES Panorama of Ependymoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
120 pages
Epidermolysis Bullosa R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF EPIDERMOLYSIS BULLOSA PIPELINE REPORT INCLUDES Panorama of Epidermolysis Bullosa pipeline markets including statistics on therapeutic drugs and companies involved Epidermolysis Bullosa Pipeline candidates across various development ...
August 2018
90 pages
Epstein Barr Viral Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF EPSTEIN BARR VIRAL INFECTIONS PIPELINE REPORT INCLUDES Panorama of Epstein Barr Viral Infections pipeline markets including statistics on therapeutic drugs and companies involved Epstein Barr Viral Infections Pipeline candidates across ...
August 2018
140 pages
Epstein–Barr Virus (HHV 4) Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF EPSTEIN–BARR VIRUS (HHV 4) INFECTIONS PIPELINE REPORT INCLUDES Panorama of Epstein–Barr Virus (HHV 4) Infections pipeline markets including statistics on therapeutic drugs and companies involved Epstein–Barr Virus (HHV 4) Infections Pipeline candidates across ...
August 2018
140 pages
Equine Encephalitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF EQUINE ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Equine Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved Equine Encephalitis Pipeline candidates across various development ...
August 2018
40 pages
Erectile Dysfunction R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF ERECTILE DYSFUNCTION PIPELINE REPORT INCLUDES Panorama of Erectile Dysfunction pipeline markets including statistics on therapeutic drugs and companies involved Erectile Dysfunction Pipeline candidates across various development ...
August 2018
90 pages
Escherichia coli Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF ESCHERICHIA COLI INFECTIONS PIPELINE REPORT INCLUDES Panorama of Escherichia coli Infections pipeline markets including statistics on therapeutic drugs and companies involved Escherichia coli Infections Pipeline candidates across various development ...
August 2018
150 pages
Essential Thrombocythemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF ESSENTIAL THROMBOCYTHEMIA PIPELINE REPORT INCLUDES Panorama of Essential Thrombocythemia pipeline markets including statistics on therapeutic drugs and companies involved Essential Thrombocythemia Pipeline candidates across various development ...
August 2018
70 pages
Essential Tremor R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF ESSENTIAL TREMOR PIPELINE REPORT INCLUDES Panorama of Essential Tremor pipeline markets including statistics on therapeutic drugs and companies involved Essential Tremor Pipeline candidates across various development ...
August 2018
40 pages
Exocrine Pancreatic Insufficiency R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF EXOCRINE PANCREATIC INSUFFICIENCY PIPELINE REPORT INCLUDES Panorama of Exocrine Pancreatic Insufficiency pipeline markets including statistics on therapeutic drugs and companies involved Exocrine Pancreatic Insufficiency Pipeline candidates across various development ...
August 2018
40 pages
Fabry Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF FABRY DISEASE PIPELINE REPORT INCLUDES Panorama of Fabry Disease pipeline markets including statistics on therapeutic drugs and companies involved Fabry Disease Pipeline candidates across various development ...
August 2018
70 pages
Familial Adenomatous Polyposis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF FAMILIAL ADENOMATOUS POLYPOSIS PIPELINE REPORT INCLUDES Panorama of Familial Adenomatous Polyposis pipeline markets including statistics on therapeutic drugs and companies involved Familial Adenomatous Polyposis Pipeline candidates across various development ...
August 2018
30 pages
Familial Amyloid Neuropathies R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF FAMILIAL AMYLOID NEUROPATHIES PIPELINE REPORT INCLUDES Panorama of Familial Amyloid Neuropathies pipeline markets including statistics on therapeutic drugs and companies involved Familial Amyloid Neuropathies Pipeline candidates across various development ...
August 2018
60 pages
Fanconi Anemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF FANCONI ANEMIA PIPELINE REPORT INCLUDES Panorama of Fanconi Anemia pipeline markets including statistics on therapeutic drugs and companies involved Fanconi Anemia Pipeline candidates across various development ...
August 2018
40 pages
Fatigue R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF FATIGUE PIPELINE REPORT INCLUDES Panorama of Fatigue pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Female Contraception R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF FEMALE CONTRACEPTION PIPELINE REPORT INCLUDES Panorama of Female Contraception pipeline markets including statistics on therapeutic drugs and companies involved Female Contraception Pipeline candidates across various development ...
August 2018
70 pages
Female Hypoactive Sexual Desire Disorder R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER PIPELINE REPORT INCLUDES Panorama of Female Hypoactive Sexual Desire Disorder pipeline markets including statistics on therapeutic drugs and companies involved Female Hypoactive Sexual Desire Disorder Pipeline candidates across ...
August 2018
40 pages
Female Sexual Dysfunction R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF FEMALE SEXUAL DYSFUNCTION PIPELINE REPORT INCLUDES Panorama of Female Sexual Dysfunction pipeline markets including statistics on therapeutic drugs and companies involved Female Sexual Dysfunction Pipeline candidates across various development ...
August 2018
50 pages
Fibrinogen Deficiency (Factor I Deficiency) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF FIBRINOGEN DEFICIENCY (FACTOR I DEFICIENCY) PIPELINE REPORT INCLUDES Panorama of Fibrinogen Deficiency (Factor I Deficiency) pipeline markets including statistics on therapeutic drugs and companies involved Fibrinogen Deficiency (Factor I Deficiency) Pipeline candidates across ...
August 2018
30 pages
Fibrodysplasia Ossificans Progressiva R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA PIPELINE REPORT INCLUDES Panorama of Fibrodysplasia Ossificans Progressiva pipeline markets including statistics on therapeutic drugs and companies involved Fibrodysplasia Ossificans Progressiva Pipeline candidates across various development ...
August 2018
50 pages
Fibromyalgia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF FIBROMYALGIA PIPELINE REPORT INCLUDES Panorama of Fibromyalgia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Fibrosarcoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF FIBROSARCOMA PIPELINE REPORT INCLUDES Panorama of Fibrosarcoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
70 pages
Fibrosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF FIBROSIS PIPELINE REPORT INCLUDES Panorama of Fibrosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
100 pages
Focal Segmental Glomerulosclerosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS PIPELINE REPORT INCLUDES Panorama of Focal Segmental Glomerulosclerosis pipeline markets including statistics on therapeutic drugs and companies involved Focal Segmental Glomerulosclerosis Pipeline candidates across various development ...
August 2018
50 pages
